Pierre Moulin
Chief Scientific Officer Diagnexia Analytix
Seminars
Tuesday 31st March 2026
Who Interprets Your Tissue Data? The Case for Embedded Pathology in Complex Biomarker Programs
2:50 pm
- Complex tissue biomarker assays require pathology expertise at design, not just at review
- Pathologists interpret data – they don't just quality-control it
- Not every assay needs GLP. Regulatory agility means applying the right compliance framework to the right stage
